Doctor profile · Federal record
Dr. Anas Al-Janadi, M.D.
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Grand Rapids, MI
- NPI 1790727360
- Accepts Medicare
- MIPS 93.8 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
145 Michigan St Ne Ste 2200
Grand Rapids, MI 495032562
(616) 486-5933 - Mailing address
-
100 Michigan St Ne # Mc845
Grand Rapids, MI 495032560
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- March 12, 2026
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Michigan #4301072694
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790727360. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
34
Distinct HCPCS
2
Medicare allowed
$3,868
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 20 | 18 | $95 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 14 | 13 | $140 |
In context: peer comparison
Among 3 peers in Grand Rapids Medical Oncology Physician, average services per provider: 56. This provider delivers 0.6× the peer median.Open Payments
Industry payments received
All-time total
$10,233
Transactions
19
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $5,800.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $2,362.50 | |
| Pfizer INC. | 1 | $545.85 | |
| Genzyme Corporation | 5 | $530.15 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $206.71 | |
| Genentech, INC. | 1 | $143.23 | |
| Genentech USA, INC. | 1 | $135.84 | |
| Janssen Biotech, INC. | 1 | $127.45 | |
| Geron Corporation | 1 | $124.45 | |
| BeiGene USA, INC. | 1 | $78.00 | |
| Adc Therapeutics America, INC. | 1 | $63.00 | |
| Amgen INC. | 1 | $44.75 | |
| Servier Pharmaceuticals LLC | 1 | $41.69 | |
| Abbvie INC. | 1 | $28.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
125
Patients
12
Total drug cost
$327,886
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 45 | 12 | $768 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 21 | 0 | $321,281 |
| Prochlorperazine Maleate | Generic | 21 | 0 | $332 |
| Dexamethasone | Generic | 15 | 0 | $571 |
| Allopurinol | Generic | 12 | 0 | $80 |
| Anagrelide Hcl | Generic | 11 | 0 | $4,855 |
Hospital affiliations
Frequently asked questions
What is Dr. Anas Al-Janadi's medical specialty?
Dr. Anas Al-Janadi practices Medical Oncology Physician in Grand Rapids, MI.
Where does Dr. Anas Al-Janadi practice?
Dr. Anas Al-Janadi practices at 145 Michigan St Ne Ste 2200, Grand Rapids, MI 495032562. Office phone: 6164865933.
What is Dr. Anas Al-Janadi's NPI?
Dr. Anas Al-Janadi's National Provider Identifier (NPI) is 1790727360, issued by NPPES.
Does Dr. Anas Al-Janadi accept Medicare assignment?
Yes. Dr. Anas Al-Janadi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Anas Al-Janadi commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.